PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 172 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,000 | -90.7% | 7,931 | -76.8% | 0.00% | -100.0% |
| Q1 2022 | $2,604,000 | +1182.8% | 34,201 | +909.2% | 0.01% | – |
| Q4 2021 | $203,000 | +1.5% | 3,389 | -4.4% | 0.00% | -100.0% |
| Q3 2021 | $200,000 | -1.5% | 3,546 | +4.8% | 0.00% | 0.0% |
| Q2 2021 | $203,000 | -14.7% | 3,383 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $238,000 | +19.0% | 3,374 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $200,000 | -23.1% | 3,374 | -22.9% | 0.00% | 0.0% |
| Q3 2020 | $260,000 | +26.8% | 4,374 | +12.2% | 0.00% | 0.0% |
| Q2 2020 | $205,000 | -13.5% | 3,900 | -29.5% | 0.00% | -50.0% |
| Q4 2018 | $237,000 | -13.5% | 5,535 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $274,000 | -0.4% | 5,603 | -6.6% | 0.00% | 0.0% |
| Q4 2017 | $275,000 | +21.7% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $226,000 | +3.2% | 6,000 | +44.7% | 0.00% | +100.0% |
| Q1 2016 | $219,000 | -32.6% | 4,147 | -1.8% | 0.00% | -75.0% |
| Q4 2015 | $325,000 | – | 4,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |